The Pharmaceutical Biotechnology Department is an interdisciplinary field encompassing a wide range of activities, including biotechnology, medical biotechnology, pharmaceutical biotechnology, enzyme and microbial biotechnology, plant biotechnology, animal biotechnology, and areas like genomics and proteomics.

Recent studies in the field of pharmaceutical biotechnology focus on identifying disease agents at the protein and gene levels, producing diagnostic molecules, developing recombinant antibodies and peptide structures, creating biological medical products of pharmaceutical biotechnology origin (protein-based drugs produced using recombinant DNA technology, monoclonal antibodies, biosimilar drugs), producing immunopharmaceuticals (vaccines), manufacturing biopolymer microspheres for disease treatment, producing and characterizing human primary and adult stem cells, developing cell technologies and vaccine technologies for protective and therapeutic purposes, producing stem cell-based drugs, DNA carrier nanomaterials, biopolymers, drug delivery systems, and engaging in tissue engineering.